EUVIMEDEUVIMED entdecken
Crossref

Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone

K. Pinnell, K. Finegan, K. Williams, S. Cartmell

European Journal of Cancer · 2026-03 · 237 · 116522

DOI: 10.1016/j.ejca.2026.116522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von K. Pinnell und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pinnell, K., Finegan, K., Williams, K., & Cartmell, S. (2026). Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone. European Journal of Cancer, 237, 116522. https://doi.org/10.1016/j.ejca.2026.116522

Vancouver

Pinnell K, Finegan K, Williams K, Cartmell S. Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone. European Journal of Cancer. 2026;237:116522. doi:10.1016/j.ejca.2026.116522

BibTeX
@article{Pinnell2026,
  author = {Pinnell, K. and Finegan, K. and Williams, K. and Cartmell, S.},
  title = {Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116522},
  doi = {10.1016/j.ejca.2026.116522}
}
Kostenlos starten →